China Medical System Holdings Limited
CHSYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,469 | $8,013 | $9,150 | $8,337 |
| % Growth | -6.8% | -12.4% | 9.8% | – |
| Cost of Goods Sold | $2,047 | $1,937 | $2,115 | $2,090 |
| Gross Profit | $5,422 | $6,076 | $7,036 | $6,247 |
| % Margin | 72.6% | 75.8% | 76.9% | 74.9% |
| R&D Expenses | $330 | $195 | $125 | $115 |
| G&A Expenses | $780 | $657 | $637 | $441 |
| SG&A Expenses | $3,442 | $3,168 | $3,358 | $2,981 |
| Sales & Mktg Exp. | $2,662 | $2,511 | $2,721 | $2,540 |
| Other Operating Expenses | -$82 | $0 | -$93 | -$65 |
| Operating Expenses | $3,690 | $3,363 | $3,390 | $3,031 |
| Operating Income | $1,733 | $2,713 | $3,552 | $3,151 |
| % Margin | 23.2% | 33.9% | 38.8% | 37.8% |
| Other Income/Exp. Net | $278 | $161 | $210 | $306 |
| Pre-Tax Income | $2,010 | $2,874 | $3,763 | $3,457 |
| Tax Expense | $397 | $489 | $487 | $431 |
| Net Income | $1,620 | $2,401 | $3,259 | $3,017 |
| % Margin | 21.7% | 30% | 35.6% | 36.2% |
| EPS | 0.67 | 0.98 | 1.33 | 1.22 |
| % Growth | -31.6% | -26.3% | 9% | – |
| EPS Diluted | 0.67 | 0.98 | 1.33 | 1.22 |
| Weighted Avg Shares Out | 2,427 | 2,452 | 2,454 | 2,468 |
| Weighted Avg Shares Out Dil | 2,427 | 2,452 | 2,454 | 2,468 |
| Supplemental Information | – | – | – | – |
| Interest Income | $126 | $146 | $106 | $82 |
| Interest Expense | $39 | $46 | $49 | $28 |
| Depreciation & Amortization | $259 | $209 | $209 | $220 |
| EBITDA | $2,308 | $2,922 | $3,762 | $3,705 |
| % Margin | 30.9% | 36.5% | 41.1% | 44.4% |